Fucose Is on the TRAIL of Colon Cancer

Slides:



Advertisements
Similar presentations
Genetic testing for high-risk colon cancer patients1 William M. Grady Gastroenterology Volume 124, Issue 6, Pages (May 2003) DOI: /S (03)
Advertisements

Volume 154, Issue 5, Pages (April 2018)
Volume 137, Issue 1, Pages e2 (July 2009)
Volume 154, Issue 5, Pages (April 2018)
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Metaplasia as a Premalignant Pathology in the Stomach
Teaching Tolerance With a Probiotic Antigen Delivery System
Byeong–Moo Kim, Michael Y. Choi  Gastroenterology 
Volume 152, Issue 4, Pages (March 2017)
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Christoph Lübbert, Babett Holler  Gastroenterology 
c-Kit as a Novel Potential Therapeutic Target in Colorectal Cancer
Is HCV Infection a Neurologic Disorder?
Lost in Inflammation: The Functional Conversion of Regulatory T Cells in Acute Hepatitis A Virus Infection  Tobias Boettler, Robert Thimme  Gastroenterology 
Covering the Cover Gastroenterology
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Volume 147, Issue 3, Pages (September 2014)
Volume 148, Issue 7, Pages (June 2015)
Gastroenterology 2011–2016: Looking Back and Forward
Making Sense of HDAC2 Mutations in Colon Cancer
From Embryonic Stem Cells to β-Cells: New Hope for Diabetics?
Volume 154, Issue 5, Pages (April 2018)
Volume 141, Issue 1, Pages (July 2011)
Clinical Challenges and Images in GI
Unusual Case of an Upset Stomach
Volume 137, Issue 1, Pages e2 (July 2009)
Volume 155, Issue 4, Pages (October 2018)
Epithelial and Mesenchymal Contribution to the Niche: A Safeguard for Intestinal Stem Cell Homeostasis  Nicholas R. Smith, Paige S. Davies, Alain D. Silk,
Ilya Gukovsky, Anna S. Gukovskaya  Gastroenterology 
Volume 153, Issue 3, Pages e16-e17 (September 2017)
Volume 135, Issue 4, Pages (October 2008)
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 150, Issue 4, Pages (April 2016)
Shrikant Anant, Courtney W. Houchen  Gastroenterology 
Volume 145, Issue 1, Pages (July 2013)
Colon Cancer: An Update and Future Directions
Volume 137, Issue 1, Pages (July 2009)
Volume 145, Issue 1, Pages (July 2013)
Singling Out Intestinal Epithelial Stem Cells
Covering the Cover Gastroenterology
Ilya Gukovsky, Anna S. Gukovskaya  Gastroenterology 
Barbara Jung, Jonas J. Staudacher, Daniel Beauchamp  Gastroenterology 
Covering the Cover Gastroenterology
Targeting Smads to Restore Transforming Growth Factor-β Signaling and Regulatory T- Cell Function in Inflammatory Bowel Disease  Deanna D. Nguyen, Scott.
Coffee and Colorectal Cancer: Grounds for Prevention?
Volume 150, Issue 5, Pages (May 2016)
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Volume 148, Issue 3, Pages (March 2015)
Volume 150, Issue 7, Pages (June 2016)
Volume 140, Issue 5, Pages (May 2011)
The Dawning of a New Editorial Board for Gastroenterology
Volume 142, Issue 5, Pages (May 2012)
Volume 156, Issue 4, Pages (March 2019)
Michiel Bronswijk, Gert De Hertogh, Marc Ferrante  Gastroenterology 
Changing of the Guards: 2011–2016 Gastroenterology Team
Volume 156, Issue 4, Pages (March 2019)
Would Free Fatty Acids Enhance Treatment of Obesity?
Volume 155, Issue 6, Pages (December 2018)
Cancer Costs Projected to Reach at Least $158 Billion in 2020
Volume 138, Issue 6, Pages (May 2010)
Guardians of the ERAD Galaxy
Reinvesting in US Biomedical Research—The Time is Now
A Necrotic Liver Mass Gastroenterology
Electronic Clinical Challenges and Images in GI
The Future of Endoscopic Retrograde Cholangiopancreatography
Controversies in Liver Transplantation for Hepatitis C
Making Cancer Quiescent: SPDEF De-Cycles Beta-Catenin
Volume 147, Issue 3, Pages (September 2014)
Covering the Cover Gastroenterology
Volume 146, Issue 4, Pages (April 2014)
Presentation transcript:

Fucose Is on the TRAIL of Colon Cancer Robert S. Haltiwanger  Gastroenterology  Volume 137, Issue 1, Pages 36-39 (July 2009) DOI: 10.1053/j.gastro.2009.05.010 Copyright © 2009 AGA Institute Terms and Conditions

Figure 1 Fucosylation pathways. GDP-fucose can be synthesized in the cytoplasm from GDP-mannose (de novo pathway) or from free fucose (salvage pathway). Once synthesized, GDP-fucose is transported into the lumen of the ER/Golgi (drawn as a single compartment for simplicity) through 1 or more transporters (the ER transporter has not been identified). Fucose is transferred from GDP-fucose to acceptor substrates in the lumen of the ER (Pofut1, Pofut2) or Golgi (all other fucosyltransferases). Pofut1 fucosylates serine/threonines in EGF-like repeats, and Pofut2 fucosylates serine/threonines in TSRs. Fucosylation leads to formation of cell-surface or secreted glycoproteins, some of which are shown on the surface of the cell or secreted. Although fucose occurs in many different types of structures, some specific examples are shown, including (from left to right): mucin-type O-glycans, N-glycans (both core and terminal fucosylation), O-fucose on TSRs, and O-fucose on EGF repeats. Note that Lewis-type structures can occur on both N-glycan or mucin-type O-glycan cores. Known functions of fucosylated glycans are shown above each structure, including selectin recognition, pathogen binding, and a variety of signaling events (Notch, TGF-β1, EGF, integrins). For a more extensive review of fucosylation, see Becker and Lowe.2 Adapted from © Smith et al., 2002. Originally published in J. Cell Biol. 158:801–815. Gastroenterology 2009 137, 36-39DOI: (10.1053/j.gastro.2009.05.010) Copyright © 2009 AGA Institute Terms and Conditions